FDA inspection
Aurobindo Pharma Ltd: FDA inspection ending Sep 24, 2010
FDA inspection 684552 · Official Action Indicated (OAI) · Medchal
Key facts
| Inspection ID | 684552 |
|---|---|
| Firm | Aurobindo Pharma Ltd |
| FEI number | 3004021229 |
| Address | Unit 3, Survey 313 & 314, Bachupally, Medchal-Malkajgiri District |
| City | Medchal |
| Country | India |
| Fiscal year | 2010 |
| Inspection end date | Sep 24, 2010 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data